Please login to the form below

Not currently logged in
Email:
Password:

UCB Pharma

This page shows the latest UCB Pharma news and features for those working in and with pharma, biotech and healthcare.

UCB launches online clinical trial tool

UCB launches online clinical trial tool

UCB launches online clinical trial tool. Aims to help patients and physicians find its studies. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

Latest news

  • UCB adds website for its Facebook-based Parkinson's community UCB adds website for its Facebook-based Parkinson's community

    disease. They could also register to receive the More than Motion magazine that UCB publishes. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • NICE approves UCB Pharma’s Cimzia NICE approves UCB Pharma’s Cimzia

    NICE approves UCB Pharma’ s Cimzia. New guidance could significantly extend the patient population it could treat. ... UCB Pharma has received a boost after NICE recommended its TNF inhibitor Cimzia for people with severe rheumatoid arthritis (RA) who

  • Acorda acquires Biotie to expand in Parkinson's disease Acorda acquires Biotie to expand in Parkinson's disease

    Tozadenant itself has been tipped to become a $400m product. Tozadenant had originally been partnered with UCB, but the pharma group handed rights back to Biotie after deciding it was not ... At the time, UCB said the decision did not reflect any safety

  • UCB trials wearable sensor for Parkinson's UCB trials wearable sensor for Parkinson's

    Digital intelligence blog. Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • NICE set to recommend seven biologics for severe rheumatoid arthritis NICE set to recommend seven biologics for severe rheumatoid arthritis

    NICE's other new final draft recommendations for severe RA also include AbbVie's Humira (adalimumab), Pfizer's Enbrel (etanercept), UCB Pharma's Cimzia (certolizumab pegol), Merck Sharp &Dohme's Simponi

More from news
Approximately 3 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • Digital health Digital health

    Clough says UCB is a role model for how pharma should approach digital health. ... UCB has stuck with it, putting the right team in place to see an end-to-end solution come to fruition - something that pharma doesn’t usually do.

  • A quest for innovative solutions A quest for innovative solutions

    A quest for innovative solutions. UCB looks to the future through a PRISM. ... Like many of the big pharmaceutical players, UCB is riding out from its well-appointed laboratories and gleaming head office corrals to prospect for pharma gold.

  • Deal Watch table for November 2014 Deal Watch table for November 2014

    For an indepth analysis of these deals, read'Pharma deals during November 2014'. ... UCB (Kremers Urban Pharma) /Advent International and Avista Capital Partners. Generics portfolio.

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    I think that one of the main challenges of the pharma industry is not being terribly efficient. ... innovation approach to finding future treatments in key for UCB areas, such as neurology and autoimmue disorders. “

  • Pharma deals during February 2013 Pharma deals during February 2013

    Pharma deals during February 2013. Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... UCB Pharma [but not GSK]) pooling its research efforts with academics (in UK, Germany and Netherland) and SMEs in a new 196m

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics